Senior Biologist (Tuberculosis), University of Dundee, 2020

Senior Biologist (Tuberculosis), University of Dundee, 2020

The School of Life Sciences at the University of Dundee is a world-class academic institution with a reputation for the excellence of its research, its high quality teaching and student experience, and the strong impact of its activities outside academia. With 900 staff from over 60 countries worldwide the School provides a dynamic, multi-national, collegiate and diverse environment with state-of-the-art laboratory, technology and teaching facilities.

We have an exciting and challenging opportunity for a highly motivated and experienced biologist to join our drug discovery team. The appointee will be involved in leading the biology aspects of a portfolio of drug discovery projects for tuberculosis (TB). They will be responsible for integrating results from our TB biology collaborators with the chemistry, computational chemistry and pharmacokinetic aspects of the program. The successful candidate will gain valuable experience in working with some of the world’s leading TB biologists as part of the TB Drug Accelerator, a unique collaboration between industry and academia aiming to identify novel TB therapeutics.

The Drug Discovery Unit (DDU) (see http://www.drugdiscovery.dundee.ac.uk) is a fully integrated drug discovery operation based within a world class Life Sciences research environment. The DDU works on both neglected diseases (TB, malaria, cryptosporidiosis, leishmaniasis and Chagas disease) and validation of novel drug targets across a range of therapeutics areas. The DDU works to Biotech style philosophy and standards, incorporating dynamic, goal driven project management. The DDU has a proven track record of delivery of pre-clinical candidates for neglected diseases.

The TB Portfolio ranges from hit ID, using both phenotypic and target-based approaches, through to identification of preclinical candidates, carried out by a team of ~15 scientists and enabled by ~$8 million of funding and multiple international collaborations with Pharma companies and leading research organisations. Currently the project has a range of projects from candidate selection phase and late lead optimisation to hit validation and target-based screening.

The post is available for an immediate start. The salary will be between £41,526 and £49,533, depending on experience.

Find out more on the job webpage.